[go: up one dir, main page]

US20130237906A1 - Liquid crystal polymer-based electro-optrode neural interface, and method for producing same - Google Patents

Liquid crystal polymer-based electro-optrode neural interface, and method for producing same Download PDF

Info

Publication number
US20130237906A1
US20130237906A1 US13/880,421 US201113880421A US2013237906A1 US 20130237906 A1 US20130237906 A1 US 20130237906A1 US 201113880421 A US201113880421 A US 201113880421A US 2013237906 A1 US2013237906 A1 US 2013237906A1
Authority
US
United States
Prior art keywords
lcp
optrode
electro
optical fiber
electrode
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/880,421
Inventor
Se-ik Park
Jin-Woo Chang
Sung June KIM
Sung Eun Lee
Seung Woo Lee
Shin Ae Kim
Kyou Sik Min
Hyo Woon Moon
Hyung-Cheul Shin
Jin Won Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MI Tech Co Ltd
Original Assignee
MI Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MI Tech Co Ltd filed Critical MI Tech Co Ltd
Assigned to M.I.TECH CO., LTD. reassignment M.I.TECH CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LEE, SEUNG WOO, MIN, KYOU SIK, CHANG, JIN-WOO, KIM, JIN WON, KIM, SHIN AE, KIM, SUNG JUNE, LEE, SUNG EUN, MOON, HYO WOON, PARK, SE-IK, SHIN, HYUNG-CHEUL
Publication of US20130237906A1 publication Critical patent/US20130237906A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526Head electrodes
    • A61N1/0529Electrodes for brain stimulation
    • A61N1/0534Electrodes for deep brain stimulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6867Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive specially adapted to be attached or implanted in a specific body part
    • A61B5/6868Brain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/388Nerve conduction study, e.g. detecting action potential of peripheral nerves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551Spinal or peripheral nerve electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0601Apparatus for use inside the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/0622Optical stimulation for exciting neural tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/00163Optical arrangements
    • A61B1/00165Optical arrangements with light-conductive means, e.g. fibre optics
    • A61B1/0017Details of single optical fibres, e.g. material or cladding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0209Special features of electrodes classified in A61B5/24, A61B5/25, A61B5/283, A61B5/291, A61B5/296, A61B5/053
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36025External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0601Apparatus for use inside the body
    • A61N2005/0612Apparatus for use inside the body using probes penetrating tissue; interstitial probes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/10Methods of surface bonding and/or assembly therefor
    • Y10T156/1052Methods of surface bonding and/or assembly therefor with cutting, punching, tearing or severing

Definitions

  • the present invention relates to a neural interface which is inserted into a body and a method of manufacturing the same and, more particularly, to a liquid crystal polymer-based electro-optrode neural interface including an electrode and an optrode integrated together, and to a method of manufacturing the same.
  • neural interfaces such as electrodes and optrodes for stimulating deep brain regions or measuring neural signals from deep brain regions are responsible for very important functions in neural prostheses such as cochlear implants, artificial thin-films, deep brain stimulators, etc., or in neuroscience research including biosignal measurement, etc.
  • the neural interfaces are used to stimulate neural tissue of animals, including human beings, or to record neural signals or biosignals generated from neutral tissue. Neural stimulation or neural signal recording is carried out using an electrical process or an optical process.
  • Electrodes are mainly manufactured using semiconductor materials such as silicon, SOT (Silicon-on-Insulator), etc., or metal materials such as platinum, tungsten, etc., through which potential differences of cells are induced or recorded (see Citation Document [1]).
  • Optrodes are made using transparent materials through which light passes, and cells may be stimulated with light using techniques such as optogenetics, etc. (see Citation Document [2]).
  • optrodes may record neural signals of cells in response to light, such as surface Plasmon, changes in transmittance of near infrared rays, etc. (see Citation Documents [3] and [4]).
  • materials for use in implantable techniques such as neural interfaces should be based on biocompatibile materials or should be composed exclusively of biocompatibile materials.
  • a material for use in manufacturing an optical neural interface has to have rigidity.
  • electrodes currently used in neural prosthetic devices are problematic in terms of very high production costs because a batch process which may decrease the production costs, such as a semiconductor process, is not used.
  • DBS Deep Brain Simulator
  • MRI scanning and ATLAS anatomical map of the brain
  • MER Micro Electrode Recording
  • stimulation electrodes are inserted using a stereotaxic operation device before electrode insertion for DES.
  • the neural signals are recorded depending on the inserted position to check the correct location of the electrode, after which the micro electrode for recording a neural signal is removed, and a stimulation electrode is inserted again.
  • insertion methods without MER using MRI information and ATLAS anatomical map of the brain.
  • Methods using anatomical map information of the brain are used to determine the final insertion position via approximate coordinate systems based on MRI or C-arm, thus shortening the operation time to thereby reduce the loss of body fluids, but it is very difficult to exactly position the stimulation electrode due to minor shifting of the brain during the operation.
  • the stimulus signal is directly recorded, separately from the neural signal in response to the cell stimulation, which is called an artifact signal.
  • This signal is formed immediately after the stimulation and has a magnitude greater than that of the neural signal. To show the response immediately after the stimulation, an additional process for removing the artifact signal is required.
  • the neural interface device to be inserted in vivo should be based on a biocompatible material and should have strength adapted to be inserted into a brain. Also, this interface should be able to be inexpensively manufactured using a batch process from the point of view that it would have a great influence on the popularization and market expansion of neural prosthetic devices.
  • the electrode used in the neural interface device an artifact signal in response to the electrical stimulation is recorded, and thus problems due to the need for an additional process for actually separating the neural signal and an additional reference electrode, and due to reduced effects owing to generation of gliosis, should be solved.
  • rapid operations should become possible, compared to conventional stereotaxic operations which require a long operation time because of MRI or CT scanning during the operation.
  • a liquid crystal polymer has strength adapted to be inserted into a brain, is biocompatible, and may be subjected to a batch process thus reducing the production cost (see Citation Documents [6] and [7]), and the stereotaxic operation may be conducted using the combined optrode and electrode and thus the operation position may be rapidly checked thereby reducing the operation time, effects due to gliosis may be reduced by the optrode as light may pass through cells to some extent (see Citation Document [9]), and also the case where the neural signal is detected with light is not affected by the artifact signal, thus simplifying the post-treatment procedure (see Citation Documents [3] and [4]).
  • an object of the present invention is to provide a liquid crystal polymer (LCP)-based electro-optrode neural interface having integrated electrode and optrode and a method of manufacturing the same.
  • LCP liquid crystal polymer
  • design and fabrication techniques of electrodes for stimulating deep brain regions enable electrode design in which an optical technique for recording a neural signal without an artifact signal and an electrode technique for electrically recording a neural signal are embodied on a single electrode.
  • LCP liquid crystal polymer
  • a semiconductor process enables the formation of various kinds of electrode site designs and multifunctional electrodes including fluidic channel, etc., and also enables the development for a coupling method with an optical fiber to achieve an optical technique.
  • an integrated electrode can be provided in such a manner that the optical fiber is surrounded with an adhesive sheet in a thermoplastic thin-film form.
  • a variety of neural signal recording methods and stimulation methods can be applied depending on needs, and the neural signal can be more exactly recorded using electrical and optical recording methods.
  • continuous disease treatment is possible using electrical stimulation as in conventional electrodes and optical stimulation as in specific cases such as generation of gliosis.
  • MER and stimulation electrode insertion can be completed using one electrode operation, and the operation time can be shortened, thus reducing burdens on patients and operators, and also the electrode position can be monitored in real time, making it possible to perform a more exact electrode insertion operation.
  • FIG. 1 is a perspective view illustrating an electro-optrode neural interface according to an embodiment of the present invention
  • FIG. 2 is a cross-sectional view taken along the line II-II of FIG. 1 illustrating the electro-optrode neural interface
  • FIG. 3 is a perspective view illustrating the electrode layer configuration of the electro-optrode neural interface of FIG. 1 ;
  • FIGS. 4 a to 4 g are a flowchart illustrating a process of manufacturing the electro-optrode neural interface of FIG. 1 ;
  • FIG. 5 is a flowchart illustrating another process of manufacturing the electro-optrode neural interface of FIG. 1 ;
  • FIG. 6 is a perspective view illustrating the entire configuration of an electro-optrode neural interface according to another embodiment of the present invention.
  • FIG. 7 is a flowchart illustrating a process of manufacturing the electro-optrode neural interface of FIG. 6 .
  • FIG. 1 is a perspective view illustrating an electro-optrode neural interface according to an embodiment of the present invention
  • FIG. 2 is a cross-sectional view taken along the line II-II of FIG. 1 illustrating the electro-optrode neural interface
  • FIG. 3 is a perspective view illustrating the electrode layer configuration of the electro-optrode neural interface of FIG. 1 .
  • the electro-optrode neural interface 100 is connected to an implanted device (not shown), so that biosignals collected in vivo are transferred to the implanted device, and the implanted device executes signal processing, storage and analysis of the transferred biosignals and sends the obtained results to the outside.
  • the electro-optrode neural interface 100 includes an optical fiber 10 which is extended so as to be insertable into the body and is positioned at a core thereof so as to form an optical electrode portion, an adhesive sheet 20 surrounding the optical fiber 10 , an LCP electrode layer 30 wound on the optical fiber 10 by means of the adhesive sheet 20 and pre-manufactured using a semiconductor process, and a stimulation electrode site 40 attached to the adhesive sheet 20 at a distal end of the LCP electrode layer 30 .
  • the LCP electrode layer 30 is made of thermoplastic low-temperature LCP or high-temperature LCP, and may form a multi-channel electrode using a semiconductor process or a MEMS process.
  • the LCP electrode layer 30 is formed with the multi-channel electrode, information about not only one place, but of various places in viva may be obtained from respective electrodes.
  • the adhesive sheet 20 functions to adhere or fix the LCP electrode layer 30 to the optical fiber 10 , and includes a low-temperature LCP film or polyurethane having adhesiveness and biocompatibility.
  • the adhesive sheet 20 and the LCP electrode layer 30 are coupled to each other to form an LCP sample 50 .
  • the LCP electrode layer 30 may be omitted, and thus the diameter of the electro-optrode neural interface may decrease.
  • the optical fiber 10 which is a part of the optical electrode, may perform optical neural signal measurement or stimulation, and acts as a lens such as an endoscope upon operation so that the interface is inserted into the body while avoiding cerebral blood vessels. Accordingly, a special optical fiber which withstands a temperature of 280 ⁇ 290° C., for example, an optical fiber made of polyimide, polyurethane, etc., is preferably used.
  • the end of the optical fiber 10 may have a hemispherical shape as illustrated in FIG. 1 , but may have a variety of shapes such as a conical shape, a flat surface, etc., depending on the cutting and processing type.
  • the stimulation electrode site 40 is made of a metal, for example, Au or Pt, having a thickness of hundreds of nanometers through which an electrical stimulation waveform passes, and executes current/optical signal recording and electrical stimulation.
  • the stimulation electrode site 40 has a fluidic channel 42 configured to inject a drug into the region in which the electrode is inserted.
  • the electro-optrode neural interface according to the present invention is formed by combining a micro electrode for recording a neural signal and a stimulation electrode, has high long-term stability, and is configured such that a neural electrode is formed using the LCP film 50 comprising the LCP electrode layer and the adhesive sheet 20 integrated with each other, and the optical fiber 10 is surrounded therewith.
  • the neural electrode using the LCP film 50 comprising the LCP electrode layer and the adhesive sheet 20 integrated with each other plays a role in recording the neural signal and performing multiple functions including electrical stimulation, drug delivery, etc., and the optical fiber 10 is responsible for recording the neural signal and for the function of the stimulation electrode.
  • the electrode insertion operation need only be completed once, thus shortening the operation time.
  • the electro-optrode neural interface according to the present invention is able to use the optical fiber as an endoscope and thus whether the cerebral blood vessel is present or not may be observed with the naked eye in real time using the overall reflective property of the optical fiber. Also, when the integration of peripheral circuits is accomplished, the electro-optrode neural interface according to the present invention enables the direction of electrode entry to be changed variously like in the case of currently used endoscopes, and may thus be developed into a future electrode that is inserted up to the stimulus position while avoiding causing damage to cerebral blood vessels, in lieu of the linear electrode insertion which is currently mainly performed. Ultimately, difficulties in monitoring the position of the electrode are solved.
  • the stimulation electrode of the invention is an optical electrode using an optical technique and thus stimulation of tissue using the optical electrode, namely, optical stimulation, is possible even when gliosis surrounds the electrode, thereby solving problems of gliosis caused by the immune response, etc.
  • an LCP electrode layer 30 which is pre-manufactured in a long tape form, an adhesive sheet 20 , and an optical fiber 10 that withstands a temperature of about 300° C. are prepared.
  • the pre-manufactured LCP electrode layer 30 may be integrated with the adhesive sheet 20 using a semiconductor process, and the LCP electrode layer and the adhesive sheet, which are integrated with each other, refer to an LCP sample 50 .
  • the manufacturing method using the LCP sample 50 is described.
  • the LCP sample 50 is densely wound on the optical fiber 10 , and the optical fiber 10 is mechanically held to a cylindrical optical fiber fixer 60 .
  • the optical fiber 10 is held by being pulled at a predetermined tension so that pressure applied to the LCP sample 50 is maintained constant.
  • the prepared LCP sample 50 is placed in a metal mold 70 and heated while being rotated.
  • the heating temperature is set so that the temperature applied to the LCP sample 50 is about 275 ⁇ 280° C., and the LCP sample 50 is rotated in non-contact type so as not to come into direct contact with the metal mold 70 .
  • This is intended to prevent thermal deformation of the optical fiber 10 , which is unnecessary and undesirable.
  • the reference numeral 72 is an alignment pin of the LCP 50 and the metal mold 70 .
  • the prepared LCP sample 50 is placed in a metal mold 70 and heated.
  • a repulsive layer 80 made of Teflon is disposed between the optical fiber 10 and the metal mold 70 in order to prevent the electrode layer from being melted and attached to the metal mold 70 during the heating.
  • the heating temperature is set so that the temperature applied to the LCP sample 50 is about 275 ⁇ 280° C. This case is performed when heat resistance of the optical fiber 10 is very high, and is advantageous because the process time is short and the roughness of the entire electrode is low.
  • a mixed heating process including the non-contact type and the contact type may be performed.
  • the mixed heating process is performed by disposing a repulsive layer 80 between the LCP sample 50 and the metal mold 70 and periodically tapping the LCP sample 50 by the metal mold 70 at a regular temporal interval, that is, repeatedly applying predetermined pressure.
  • the LCP sample 50 is heated while being rotated in the metal mold 70 .
  • the heating temperature is set so that the temperature applied to the LCP sample 50 is about 275 ⁇ 280° C.
  • the thermal deformation of the optical fiber 10 which is unnecessary and undesirable, is prevented.
  • the above-mentioned heating process enables the LCP electrode layer to be melted by means of heat and pressure so as to attach the adhesive sheet and the optical fiber to each other. This refers to lamination. While the LCP electrode layer is melted under predetermined temperature and pressure conditions, it is coupled to the optical fiber.
  • the tip of the optical fiber 10 which is unnecessarily long, is cut using a fiber cutter, thus manufacturing the electro-optrode neural interface 100 according to the present invention.
  • a stimulation electrode site 40 is attached to the manufactured electro-optrode neural interface 100 .
  • the portion where the optical fiber 10 is exposed is responsible for recording the neural signal using the optical signal, checking for the presence of the cerebral blood vessel upon an electrode insertion operation to execute optical simulation, and measuring the reflectance of the optical signal during the insertion, so that the position of the inserted electro-optrode neural interface may be monitored in real time. Even when gliosis occurs, deep brain stimulation effects may be induced via optical stimulation.
  • the stimulation electrode site 40 wherein the electrical signal is recorded and the electrical stimulation is executed may have multiple channels depending on the type of design, and impedance or charge injection limit may become diversified depending on the material for the site.
  • FIG. 5 illustrates another process of manufacturing the electro-optrode neural interface.
  • a prepared LCP sample 50 is disposed at upper and lower positions of an optical fiber 10 , and a repulsive layer 80 is disposed between the optical fiber 10 and a metal mold 70 , and the resulting sample is placed in the metal mold 70 .
  • the metal mold 70 is heated. Accordingly, the LCP sample 50 at the upper and lower positions of the optical fiber 10 is fused and transformed so as to surround the optical fiber 10 . During the heating, the transformation of the LCP sample 50 , that is, low-temperature LCP material is induced at 270° C. for a predetermined period of time, after which heating is carried out under pressure so that the heating temperature is about 275 ⁇ 280° C.
  • FIG. 6 is a perspective view illustrating an electro-optrode neural interface according to another embodiment of the present invention.
  • the electro-optrode neural interface 200 according to another embodiment of the present invention includes a substrate portion 210 made of high-temperature or low-temperature LCP, electrode portions 220 formed on the upper side of the substrate portion 210 and spaced apart from each other to collect biosignals and to transfer the collected biosignals, and an optrode portion 240 formed on the upper side of the substrate portion 210 between the electrode portions 220 to form an optical electrode portion.
  • the electro-optrode interface 200 is connected to an implanted device (not shown), so that biosignals collected in vivo are transferred to the implanted device, and the implanted device performs signal processing, storage and analysis of the transferred biosignals and sends the obtained results to the outside.
  • the electrode portions 220 are formed by patterning a metal such as Au on the substrate portion 210 .
  • the electrode portions 220 may be formed with a multi-channel electrode, or may be formed using a MEMS process.
  • the optrode portion 240 is formed by patterning a patternable transparent material, that is, a photopolymer such as SU-8, and may be formed to be a desired size, enables light to pass therethrough, and may be formed using a MEMS process.
  • a patternable transparent material that is, a photopolymer such as SU-8
  • the substrate portion 210 functions to protect the electrode portions 220 and the optrode portion 240 , and is made of LCP, especially low-temperature LCP.
  • the electro-optrode neural interface 200 further includes a cover portion 260 layered on the substrate portion 210 so as to protect the electrode portions 220 and the optrode portion 240 .
  • the cover portion 260 is formed using hot pressing on the substrate portion 210 , and is made of high-temperature or low-temperature LCP, especially low-temperature LCP, as in the substrate portion 210 .
  • an adhesive layer of low-temperature LCP may be additionally required between the substrate portion 210 and the cover portion 260 .
  • the electro-optrode neural interface according to another embodiment of the present invention is manufactured as illustrated in FIG. 7 .
  • the upper side of a substrate portion 210 having an approximate rectangular shape is subjected to Au patterning, thus forming electrode portions 220 extended in a longitudinal direction of the substrate portion 210 and spaced apart from each other. Subsequently, the space between the electrode portions 220 is patterned with a photopolymer such as SU-8 so as not to overlap with the electrode portions 220 formed on the substrate portion 210 , thus forming an optrode portion 240 .
  • a photopolymer such as SU-8
  • a cover portion 260 made of LCP is placed on the substrate portion 210 having the electrode portions 220 and the optrode portion 240 formed thereon and then laminated. As such, the cover portion 260 is laminated so as to provide exposure portions 242 and 246 which expose parts of the electrode portions 220 and the optrode portion 240 .
  • the exposure portion 242 is formed close to the insertion direction of the body, through which biosignals are collected.
  • the exposure portion 246 which is located opposite to the exposure portion 242 , functions to transfer the biosignals collected by the exposure portion 242 to an implanted device (not shown).
  • a part of the substrate portion 210 other than the electrode portions 220 and the optrode portion 240 formed on the substrate portion 210 laminated with the cover portion 260 is cut using a laser, thus manufacturing the electro-optrode neural interface 200 as illustrated in FIG. 6 .
  • alignment holes 262 are formed in the interface, and the feed-through 280 is connected using the alignment holes 262 .
  • the feed-through 280 includes an electrical cable 282 so that the electrode portions 220 are connected to an electrical circuit element of the implanted device, and the optrode portion 240 is connected to a measurement element of the implanted device which measures the generation of an optical signal.
  • the feed-through is coated with an insulating material so as to prevent it from being exposed to the outside.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Optics & Photonics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Developmental Disabilities (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Social Psychology (AREA)
  • Electrotherapy Devices (AREA)
  • Liquid Crystal (AREA)
  • Endoscopes (AREA)
  • Prostheses (AREA)

Abstract

The invention relates to an electro-optrode neural interface, comprising an optical fiber which is elongated so as to be insertable into a body, and which is located at a core portion so as to form an optical electrode portion, and a liquid crystal polymer(LCP) sample encircling the optical fiber. The LCP sample has an adhesive sheet, and an LCP electrode layer encircling the adhesive sheet, wherein the adhesive sheet and the LCP electrode layer are coupled to each other. The electro-optrode neural interface is formed by combining into a single unit, an electrical interface in which an electrode for stimulating deep brain or measuring neural signals from deep brain is arranged in a liquid crystal polymet and an optical interface such as an optical fiber, a waveguide and an endoscope. The electro-optrode interface of the present invention may enable an electro-optrode to be inserted into a body which electrically or optically monitoring the position of the electro-optrode in real time, and may be mass producted.

Description

    TECHNICAL FIELD
  • The present invention relates to a neural interface which is inserted into a body and a method of manufacturing the same and, more particularly, to a liquid crystal polymer-based electro-optrode neural interface including an electrode and an optrode integrated together, and to a method of manufacturing the same.
  • BACKGROUND ART
  • As is well known in the art, neural interfaces such as electrodes and optrodes for stimulating deep brain regions or measuring neural signals from deep brain regions are responsible for very important functions in neural prostheses such as cochlear implants, artificial thin-films, deep brain stimulators, etc., or in neuroscience research including biosignal measurement, etc. The neural interfaces are used to stimulate neural tissue of animals, including human beings, or to record neural signals or biosignals generated from neutral tissue. Neural stimulation or neural signal recording is carried out using an electrical process or an optical process.
  • Electrodes are mainly manufactured using semiconductor materials such as silicon, SOT (Silicon-on-Insulator), etc., or metal materials such as platinum, tungsten, etc., through which potential differences of cells are induced or recorded (see Citation Document [1]).
  • Optrodes are made using transparent materials through which light passes, and cells may be stimulated with light using techniques such as optogenetics, etc. (see Citation Document [2]).
  • Also, optrodes may record neural signals of cells in response to light, such as surface Plasmon, changes in transmittance of near infrared rays, etc. (see Citation Documents [3] and [4]).
  • However, conventional materials for electrodes or optrodes have mechanical properties which deteriorate easily, such as in silicon, or have poor rigidity making them unsuitable for use in a brain and thus requiring additional supports. Hence, such materials are mostly limited in applications to implantable neural interfaces, and methods using supports, etc., should be devised (see Citation Document [5]).
  • Also, materials for use in implantable techniques such as neural interfaces should be based on biocompatibile materials or should be composed exclusively of biocompatibile materials. In the case where a neural interface is applied to a deep brain region, because there should be no undesirable effects caused by the support in the course of signal transmission via the neural interface, a material for use in manufacturing an optical neural interface has to have rigidity. Furthermore, electrodes currently used in neural prosthetic devices are problematic in terms of very high production costs because a batch process which may decrease the production costs, such as a semiconductor process, is not used.
  • Because materials for neural interfaces of neural prosthetic devices, to which a batch process may be applied in future, are sufficiently competitive, those having strength adapted to be inserted into a brain, being biocompatible and able to decrease the production costs using a batch process are advantageously required.
  • However, most conventional techniques concerning electrodes or optrodes have been separately studied and tested. In some research groups, prior research into combining these two techniques to construct neural interfaces in vitro was conducted, but research in vivo has not yet been introduced.
  • Also, when combinations of optrodes and electrodes are applied to stereotaxic operation, it will be expected that the operation position may be rapidly checked, thus shortening the operation time and reducing effects caused by gliosis due to immune responses and effects of artifact signals by stimulation, but neural interfaces having combined optrodes and electrodes are not structures that can be applied to stereotaxic operation (see Citation Document [8]).
  • For example, in the case of an electrode insertion operation for DBS (Deep Brain Simulator), it is conventionally conducted in such a manner that the insertion position is checked using MRI scanning and ATLAS (anatomical map of the brain) before the electrode insertion operation, and the operation is carried out using stereotaxic operation equipment.
  • However, it is difficult to execute the operation because of diverse factors including different brain positions or unique brain structures in each person. To solve such problems, methods wherein neural signals are recorded using MER (Micro Electrode Recording) and then stimulation electrodes are inserted are being mainly adopted. In these methods, a micro electrode for recording a neural signal is inserted using a stereotaxic operation device before electrode insertion for DES. The neural signals are recorded depending on the inserted position to check the correct location of the electrode, after which the micro electrode for recording a neural signal is removed, and a stimulation electrode is inserted again. This is because, upon puncturing of the skull to form a bur hole, the pressure of the skull changes and the spinal fluid of the brain flows out of the brain, and thus there occurs a shift in which the position of the brain is changed and is different than it would be during MRI scanning.
  • However this method has problems, as follows. {circle around (1)} The operation time is lengthened, undesirably increasing loss of body fluids including the spinal fluid of the brain, blood, etc. {circle around (2)} Two kinds of electrodes are alternately inserted, undesirably increasing the risk of injury to cerebral blood vessels (the recording electrode has a smaller diameter than the stimulation electrode). {circle around (3)} The insertion position of the stimulation electrode is adjusted to a different position, instead of the insertion route of the recording electrode, unnecessarily causing damage to the brain tissue.
  • Unlike this, there are proposed insertion methods without MER using MRI information and ATLAS (anatomical map of the brain). Methods using anatomical map information of the brain are used to determine the final insertion position via approximate coordinate systems based on MRI or C-arm, thus shortening the operation time to thereby reduce the loss of body fluids, but it is very difficult to exactly position the stimulation electrode due to minor shifting of the brain during the operation.
  • When a specific external object is implanted in vivo, there occurs gliosis in which the brain tissue encloses the electrode recognized as an impurity due to the immune response. In this case, transmission of a stimulus electrical signal to the tissue to be stimulated by the electrode may become problematic, thus reducing stimulation effects and therapeutic effects. Hence, in order to provide appropriate stimulation effects, there may occur a situation in which the electrode insertion operation should be carried out again at an alternative position, undesirably increasing a burden on a patient. In the case of the electrode inserted into the brain, all of a series of procedures, from MRI scanning to the insertion operation, should be undesirably conducted again.
  • Finally in the case where electrical stimulation is applied to cells and the neural signal is recorded with the electrode, the stimulus signal is directly recorded, separately from the neural signal in response to the cell stimulation, which is called an artifact signal. This signal is formed immediately after the stimulation and has a magnitude greater than that of the neural signal. To show the response immediately after the stimulation, an additional process for removing the artifact signal is required.
  • As mentioned above, the neural interface device to be inserted in vivo should be based on a biocompatible material and should have strength adapted to be inserted into a brain. Also, this interface should be able to be inexpensively manufactured using a batch process from the point of view that it would have a great influence on the popularization and market expansion of neural prosthetic devices. In the case of the electrode used in the neural interface device, an artifact signal in response to the electrical stimulation is recorded, and thus problems due to the need for an additional process for actually separating the neural signal and an additional reference electrode, and due to reduced effects owing to generation of gliosis, should be solved. Moreover, rapid operations should become possible, compared to conventional stereotaxic operations which require a long operation time because of MRI or CT scanning during the operation.
  • The present inventors have found that a liquid crystal polymer has strength adapted to be inserted into a brain, is biocompatible, and may be subjected to a batch process thus reducing the production cost (see Citation Documents [6] and [7]), and the stereotaxic operation may be conducted using the combined optrode and electrode and thus the operation position may be rapidly checked thereby reducing the operation time, effects due to gliosis may be reduced by the optrode as light may pass through cells to some extent (see Citation Document [9]), and also the case where the neural signal is detected with light is not affected by the artifact signal, thus simplifying the post-treatment procedure (see Citation Documents [3] and [4]).
  • CITATION LIST Patent Literature
    • [1] U.S. Pat. No. 6,644,552 (Registration date: Nov. 4, 2003)
    • [2] Korean Unexamined Patent Application No. 2010-0081862 (Laid-open date: Jul. 15, 2010)
    • [3] Korean Unexamined Patent Application No. 2010-0056876 (Laid-open date: May 28, 2010)
    • [4] Korean Unexamined Patent Application No. 2010-0056872 (Laid-open date: May 28, 2010)
    • [5] Korean Unexamined Patent Application No. 2010-0010714 (Laid-open date: Feb. 2, 2010)
    Non-Patent Literature
    • [1] “A High-Yield Fabrication Process for Silicon Neural Probes”, Seung Jae Oh, Jong Keun Song, Jin Won Kim, and Sung June Kim, IEEE Transactions on Biomedical Engineering, Vol. 53, no. 2, pp. 351-354, February 2006.
    • [2] “Next-generation optical technologies for illuminating genetically targeted brain circuits”. Deisseroth K, Feng G, Majewska A K, Miesenbock G, Ting A, Schnitzer M J, J. Neurosci. 26 (41): 10380-10386, October 2006.
    • [3] “Spectrum measurement of fast optical signal of neural activity in brain tissue and its theoretical origin”, Jonghwan Lee and Sung June Kim, NeuroImage, Vol. 51, no. 2, pp. 713-722, 2010.
    • [4] “Optical Measurement of Neural Activity Using Surface Plasmon Resonance”, Shin Ae Kim, Kyung Min Byun, Jonghwan Lee, Jung Hoon Kim, Dong-Ghi Albert Kim, Hyoungwon Baac, Michael L. Shuler, and Sung June Kim, Optics Letters, Vol. 33, no. 9, pp. 914-916, May. 2008.
    • [5] “Polyimide based neural implants with stiffness improvement”, Keekeun Lee, Amarjit Singh, Jiping He, Stephen Massia, Bruce Kim, Gregory Raupp, Sensors and Actuators B, Vol. 102, Issue 1, pp. 67-72, September 2004
    • [6]“Development of microelectrode arrays for artificial retinal implants using liquid crystal polymers”, S. W. Lee, J. M. Seo, S. Ha, E. T. Kim, H. Chung, and S. J. Kim, Invest Ophthalmol Vis Sci, Vol. 50, no. 12, pp. 5859-5866, December 2009.
    • [7] M. S. Thesis, “A Study on a LCP-based Depth-type Neural Probe”, S. E. Lee, Department of electrical engineering and computer science, College of Engineering, Seoul National University, Seoul, Korea, 2010.
    • [8]“A 16-site neural probe integrated with a waveguide for optical stimulation”, I.-J. Cho, H. W. Baac, and E. Yoon, in Proc. MEMS 2010 Conference, Hong Kong, China, Jan. 24-28, 2010, pp. 995-998.
    • [9] Optical Absorption of Untreated and Laser-irradiated Tissues, D. K. SARDAR, B. M. ZAPATA, C. H. HOWARD, Lasers in Medical Science 1993, 8:205-209
    • [10] Polymer-Based Microelectrode Arrays, Scott Corbertt, Joe Ketterl, and Tim Johnson, Master, Res. Soc. Symp. Proc, Vol. 926
    • [11] Novel Biomedical Implant Interconnects Utilizing Micromachined LCP, Robert Dean, Jenny Weller, Mike Bozack, Brian Farrell, Linas Jauniskis, Josept Ting, David Edell, Jamile Hetke, Proc. of SPIE Vol. 5515
    DISCLOSURE Technical Problem
  • Accordingly, an object of the present invention is to provide a liquid crystal polymer (LCP)-based electro-optrode neural interface having integrated electrode and optrode and a method of manufacturing the same.
  • Technical Solution Advantageous Effects
  • According to embodiments of the present invention, design and fabrication techniques of electrodes for stimulating deep brain regions, including the combination of optical technology and electrical and electronic technology, enable electrode design in which an optical technique for recording a neural signal without an artifact signal and an electrode technique for electrically recording a neural signal are embodied on a single electrode. Further, the use of LCP (liquid crystal polymer) and a semiconductor process enables the formation of various kinds of electrode site designs and multifunctional electrodes including fluidic channel, etc., and also enables the development for a coupling method with an optical fiber to achieve an optical technique. Furthermore, an integrated electrode can be provided in such a manner that the optical fiber is surrounded with an adhesive sheet in a thermoplastic thin-film form. A variety of neural signal recording methods and stimulation methods can be applied depending on needs, and the neural signal can be more exactly recorded using electrical and optical recording methods. Moreover, continuous disease treatment is possible using electrical stimulation as in conventional electrodes and optical stimulation as in specific cases such as generation of gliosis. MER and stimulation electrode insertion can be completed using one electrode operation, and the operation time can be shortened, thus reducing burdens on patients and operators, and also the electrode position can be monitored in real time, making it possible to perform a more exact electrode insertion operation.
  • DESCRIPTION OF DRAWINGS
  • FIG. 1 is a perspective view illustrating an electro-optrode neural interface according to an embodiment of the present invention;
  • FIG. 2 is a cross-sectional view taken along the line II-II of FIG. 1 illustrating the electro-optrode neural interface;
  • FIG. 3 is a perspective view illustrating the electrode layer configuration of the electro-optrode neural interface of FIG. 1;
  • FIGS. 4 a to 4 g are a flowchart illustrating a process of manufacturing the electro-optrode neural interface of FIG. 1;
  • FIG. 5 is a flowchart illustrating another process of manufacturing the electro-optrode neural interface of FIG. 1;
  • FIG. 6 is a perspective view illustrating the entire configuration of an electro-optrode neural interface according to another embodiment of the present invention; and
  • FIG. 7 is a flowchart illustrating a process of manufacturing the electro-optrode neural interface of FIG. 6.
  • BEST MODE
  • Hereinafter, a detailed description will be given of embodiments of the present invention with reference to the appended drawings.
  • FIG. 1 is a perspective view illustrating an electro-optrode neural interface according to an embodiment of the present invention, FIG. 2 is a cross-sectional view taken along the line II-II of FIG. 1 illustrating the electro-optrode neural interface, and FIG. 3 is a perspective view illustrating the electrode layer configuration of the electro-optrode neural interface of FIG. 1.
  • As illustrated in FIGS. 1 to 3, the electro-optrode neural interface 100 according to the embodiment of the present invention is connected to an implanted device (not shown), so that biosignals collected in vivo are transferred to the implanted device, and the implanted device executes signal processing, storage and analysis of the transferred biosignals and sends the obtained results to the outside. The electro-optrode neural interface 100 includes an optical fiber 10 which is extended so as to be insertable into the body and is positioned at a core thereof so as to form an optical electrode portion, an adhesive sheet 20 surrounding the optical fiber 10, an LCP electrode layer 30 wound on the optical fiber 10 by means of the adhesive sheet 20 and pre-manufactured using a semiconductor process, and a stimulation electrode site 40 attached to the adhesive sheet 20 at a distal end of the LCP electrode layer 30.
  • The LCP electrode layer 30 is made of thermoplastic low-temperature LCP or high-temperature LCP, and may form a multi-channel electrode using a semiconductor process or a MEMS process. When the LCP electrode layer 30 is formed with the multi-channel electrode, information about not only one place, but of various places in viva may be obtained from respective electrodes.
  • The adhesive sheet 20 functions to adhere or fix the LCP electrode layer 30 to the optical fiber 10, and includes a low-temperature LCP film or polyurethane having adhesiveness and biocompatibility. The adhesive sheet 20 and the LCP electrode layer 30 are coupled to each other to form an LCP sample 50. In the case where the LCP electrode layer 30 is integrated with the adhesive sheet 20 using a semiconductor process, like the LCP sample 50, the LCP electrode layer 30 may be omitted, and thus the diameter of the electro-optrode neural interface may decrease.
  • The optical fiber 10, which is a part of the optical electrode, may perform optical neural signal measurement or stimulation, and acts as a lens such as an endoscope upon operation so that the interface is inserted into the body while avoiding cerebral blood vessels. Accordingly, a special optical fiber which withstands a temperature of 280˜290° C., for example, an optical fiber made of polyimide, polyurethane, etc., is preferably used. The end of the optical fiber 10 may have a hemispherical shape as illustrated in FIG. 1, but may have a variety of shapes such as a conical shape, a flat surface, etc., depending on the cutting and processing type.
  • The stimulation electrode site 40 is made of a metal, for example, Au or Pt, having a thickness of hundreds of nanometers through which an electrical stimulation waveform passes, and executes current/optical signal recording and electrical stimulation. The stimulation electrode site 40 has a fluidic channel 42 configured to inject a drug into the region in which the electrode is inserted.
  • The electro-optrode neural interface according to the present invention is formed by combining a micro electrode for recording a neural signal and a stimulation electrode, has high long-term stability, and is configured such that a neural electrode is formed using the LCP film 50 comprising the LCP electrode layer and the adhesive sheet 20 integrated with each other, and the optical fiber 10 is surrounded therewith.
  • The neural electrode using the LCP film 50 comprising the LCP electrode layer and the adhesive sheet 20 integrated with each other plays a role in recording the neural signal and performing multiple functions including electrical stimulation, drug delivery, etc., and the optical fiber 10 is responsible for recording the neural signal and for the function of the stimulation electrode.
  • As the neural signal recording electrode and the stimulation electrode are integrated with each other, the electrode insertion operation need only be completed once, thus shortening the operation time.
  • The electro-optrode neural interface according to the present invention is able to use the optical fiber as an endoscope and thus whether the cerebral blood vessel is present or not may be observed with the naked eye in real time using the overall reflective property of the optical fiber. Also, when the integration of peripheral circuits is accomplished, the electro-optrode neural interface according to the present invention enables the direction of electrode entry to be changed variously like in the case of currently used endoscopes, and may thus be developed into a future electrode that is inserted up to the stimulus position while avoiding causing damage to cerebral blood vessels, in lieu of the linear electrode insertion which is currently mainly performed. Ultimately, difficulties in monitoring the position of the electrode are solved.
  • Although gliosis is not entirely avoided when using external materials, the stimulation electrode of the invention is an optical electrode using an optical technique and thus stimulation of tissue using the optical electrode, namely, optical stimulation, is possible even when gliosis surrounds the electrode, thereby solving problems of gliosis caused by the immune response, etc.
  • The method of manufacturing the electro-optrode neural interface according to the present invention is described below with reference to FIG. 4.
  • As illustrated in FIG. 4 a, an LCP electrode layer 30, which is pre-manufactured in a long tape form, an adhesive sheet 20, and an optical fiber 10 that withstands a temperature of about 300° C. are prepared. The pre-manufactured LCP electrode layer 30 may be integrated with the adhesive sheet 20 using a semiconductor process, and the LCP electrode layer and the adhesive sheet, which are integrated with each other, refer to an LCP sample 50. For the sake of description, the manufacturing method using the LCP sample 50 is described.
  • Subsequently, as illustrated in FIG. 4 b, the LCP sample 50 is densely wound on the optical fiber 10, and the optical fiber 10 is mechanically held to a cylindrical optical fiber fixer 60. As such, the optical fiber 10 is held by being pulled at a predetermined tension so that pressure applied to the LCP sample 50 is maintained constant.
  • Subsequently, as illustrated in FIG. 4 c (the right is a cross-sectional view in the arrow direction), the prepared LCP sample 50 is placed in a metal mold 70 and heated while being rotated. The heating temperature is set so that the temperature applied to the LCP sample 50 is about 275˜280° C., and the LCP sample 50 is rotated in non-contact type so as not to come into direct contact with the metal mold 70. This is intended to prevent thermal deformation of the optical fiber 10, which is unnecessary and undesirable. In the drawing, the reference numeral 72 is an alignment pin of the LCP 50 and the metal mold 70.
  • As an alternative heating process, as illustrated in FIG. 4 d (the right is a cross-sectional view in the arrow direction), the prepared LCP sample 50 is placed in a metal mold 70 and heated. A repulsive layer 80 made of Teflon is disposed between the optical fiber 10 and the metal mold 70 in order to prevent the electrode layer from being melted and attached to the metal mold 70 during the heating. The heating temperature is set so that the temperature applied to the LCP sample 50 is about 275˜280° C. This case is performed when heat resistance of the optical fiber 10 is very high, and is advantageous because the process time is short and the roughness of the entire electrode is low.
  • As another alternative heating process, a mixed heating process including the non-contact type and the contact type may be performed. As illustrated in FIG. 4 e (the right is a cross-sectional view in the arrow direction), the mixed heating process is performed by disposing a repulsive layer 80 between the LCP sample 50 and the metal mold 70 and periodically tapping the LCP sample 50 by the metal mold 70 at a regular temporal interval, that is, repeatedly applying predetermined pressure. Furthermore, the LCP sample 50 is heated while being rotated in the metal mold 70. The heating temperature is set so that the temperature applied to the LCP sample 50 is about 275˜280° C. As the metal mold 70 comes into periodic contact with the LCP sample 50, the thermal deformation of the optical fiber 10, which is unnecessary and undesirable, is prevented.
  • The above-mentioned heating process enables the LCP electrode layer to be melted by means of heat and pressure so as to attach the adhesive sheet and the optical fiber to each other. This refers to lamination. While the LCP electrode layer is melted under predetermined temperature and pressure conditions, it is coupled to the optical fiber.
  • After completion of the heating process, as illustrated in FIG. 4 f, the tip of the optical fiber 10, which is unnecessarily long, is cut using a fiber cutter, thus manufacturing the electro-optrode neural interface 100 according to the present invention.
  • Finally, as illustrated in FIG. 4 g, a stimulation electrode site 40 is attached to the manufactured electro-optrode neural interface 100. In the electro-optrode neural interface 100, the portion where the optical fiber 10 is exposed is responsible for recording the neural signal using the optical signal, checking for the presence of the cerebral blood vessel upon an electrode insertion operation to execute optical simulation, and measuring the reflectance of the optical signal during the insertion, so that the position of the inserted electro-optrode neural interface may be monitored in real time. Even when gliosis occurs, deep brain stimulation effects may be induced via optical stimulation.
  • The stimulation electrode site 40 wherein the electrical signal is recorded and the electrical stimulation is executed may have multiple channels depending on the type of design, and impedance or charge injection limit may become diversified depending on the material for the site.
  • FIG. 5 illustrates another process of manufacturing the electro-optrode neural interface.
  • As illustrated in FIG. 5, a prepared LCP sample 50 is disposed at upper and lower positions of an optical fiber 10, and a repulsive layer 80 is disposed between the optical fiber 10 and a metal mold 70, and the resulting sample is placed in the metal mold 70.
  • Subsequently, the metal mold 70 is heated. Accordingly, the LCP sample 50 at the upper and lower positions of the optical fiber 10 is fused and transformed so as to surround the optical fiber 10. During the heating, the transformation of the LCP sample 50, that is, low-temperature LCP material is induced at 270° C. for a predetermined period of time, after which heating is carried out under pressure so that the heating temperature is about 275˜280° C.
  • Subsequently, a necessary portion is cut using laser processing, and a heating process is performed, thereby forming a final electro-optrode neural interface.
  • FIG. 6 is a perspective view illustrating an electro-optrode neural interface according to another embodiment of the present invention. As illustrated in FIG. 6, the electro-optrode neural interface 200 according to another embodiment of the present invention includes a substrate portion 210 made of high-temperature or low-temperature LCP, electrode portions 220 formed on the upper side of the substrate portion 210 and spaced apart from each other to collect biosignals and to transfer the collected biosignals, and an optrode portion 240 formed on the upper side of the substrate portion 210 between the electrode portions 220 to form an optical electrode portion.
  • The electro-optrode interface 200 according to the present invention is connected to an implanted device (not shown), so that biosignals collected in vivo are transferred to the implanted device, and the implanted device performs signal processing, storage and analysis of the transferred biosignals and sends the obtained results to the outside.
  • The electrode portions 220 are formed by patterning a metal such as Au on the substrate portion 210. The electrode portions 220 may be formed with a multi-channel electrode, or may be formed using a MEMS process.
  • The optrode portion 240 is formed by patterning a patternable transparent material, that is, a photopolymer such as SU-8, and may be formed to be a desired size, enables light to pass therethrough, and may be formed using a MEMS process.
  • The substrate portion 210 functions to protect the electrode portions 220 and the optrode portion 240, and is made of LCP, especially low-temperature LCP.
  • With reference to FIG. 7, the electro-optrode neural interface 200 further includes a cover portion 260 layered on the substrate portion 210 so as to protect the electrode portions 220 and the optrode portion 240.
  • The cover portion 260 is formed using hot pressing on the substrate portion 210, and is made of high-temperature or low-temperature LCP, especially low-temperature LCP, as in the substrate portion 210. In the case of high-temperature LCP, an adhesive layer of low-temperature LCP may be additionally required between the substrate portion 210 and the cover portion 260.
  • The electro-optrode neural interface according to another embodiment of the present invention is manufactured as illustrated in FIG. 7.
  • The upper side of a substrate portion 210 having an approximate rectangular shape is subjected to Au patterning, thus forming electrode portions 220 extended in a longitudinal direction of the substrate portion 210 and spaced apart from each other. Subsequently, the space between the electrode portions 220 is patterned with a photopolymer such as SU-8 so as not to overlap with the electrode portions 220 formed on the substrate portion 210, thus forming an optrode portion 240.
  • A cover portion 260 made of LCP is placed on the substrate portion 210 having the electrode portions 220 and the optrode portion 240 formed thereon and then laminated. As such, the cover portion 260 is laminated so as to provide exposure portions 242 and 246 which expose parts of the electrode portions 220 and the optrode portion 240. The exposure portion 242 is formed close to the insertion direction of the body, through which biosignals are collected. The exposure portion 246, which is located opposite to the exposure portion 242, functions to transfer the biosignals collected by the exposure portion 242 to an implanted device (not shown).
  • Subsequently, a part of the substrate portion 210 other than the electrode portions 220 and the optrode portion 240 formed on the substrate portion 210 laminated with the cover portion 260 is cut using a laser, thus manufacturing the electro-optrode neural interface 200 as illustrated in FIG. 6.
  • To connect a feed-through 280 to the manufactured electro-optrode neural interface 200, alignment holes 262 are formed in the interface, and the feed-through 280 is connected using the alignment holes 262.
  • The feed-through 280 includes an electrical cable 282 so that the electrode portions 220 are connected to an electrical circuit element of the implanted device, and the optrode portion 240 is connected to a measurement element of the implanted device which measures the generation of an optical signal. The feed-through is coated with an insulating material so as to prevent it from being exposed to the outside.
  • Although the preferred embodiments of the present invention regarding the LCP-based electro-optrode neural interface and the method of manufacturing the same according to the present invention have been disclosed for illustrative purposes, the present invention is not limited to such embodiments, and those skilled in the art will appreciate that various modifications, additions and substitutions are possible, without departing from the scope and spirit of the invention as disclosed in the accompanying claims.

Claims (14)

1. A liquid crystal polymer (LCP)-based electro-optrode neural interface, comprising:
an optical fiber, which is extended to be insertable into a body and is positioned at a core thereof so as to form an optical electrode portion; and
an LCP sample surrounding the optical fiber,
wherein the LCP sample includes an adhesive sheet and an LCP electrode layer surrounding the adhesive sheet and coupled to the adhesive sheet.
2. The electro-optrode neural interface of claim 1, wherein the optical fiber comprises a material which withstands a temperature of 280˜290° C.
3. The electro-optrode neural interface of claim 1, wherein the LCP electrode layer includes an electrode of an electrical stimulation site made of a multi-channel metal layer using a semiconductor process or a MEMS process,
the electro-optrode neural interface includes an interface made of the optical fiber to perform optical neural signal recording and stimulation, and
the electrical stimulation site includes a fluidic channel configured to inject a drug into a region where the electrode is inserted, in addition to current/optical signal recording and stimulation.
4. A method of manufacturing an LCP-based electro-optrode neural interface, comprising:
winding an LCP sample on an optical fiber;
heating the LCP sample wound on the optical fiber using a metal mold so that the LCP sample is laminated on the optical fiber; and
cutting an unnecessary tip of the optical fiber laminated with the LCP sample, thus forming the electro-optrode neural interface.
5. The method of claim 4, wherein the heating comprises placing the LCP sample wound on the optical fiber in the metal mold and heating it while being rotated, and the metal mold and the LCP sample do not come into direct contact with each other.
6. The method of claim 4, wherein the heating is performed so that a temperature applied to the LCP sample is 275˜285° C.
7. The method of claim 4, wherein the heating comprises placing the LCP sample wound on the optical fiber in the metal mold and heating it.
8. The method of claim 4, wherein the heating comprises placing the LCP sample wound on the optical fiber in the metal mold and heating it while being rotated, and is performed in such a manner that the LCP sample is periodically tapped by the metal mold at a predetermined temporal interval.
9. The method of claim 4, wherein the heating comprises disposing the LCP sample at upper and lower positions of the optical fiber, placing the LCP sample and the optical fiber in the metal mold, and heating them.
10. An LCP-based electro-optrode neural interface, comprising:
a substrate portion made of LCP;
electrode portions formed on an upper side of the substrate portion to collect biosignals and to transfer the collected biosignals;
an optrode portion formed on the upper side of the substrate portion so as not to overlap with the electrode portions in order to form an optical electrode portion; and
a cover portion made of LCP, protecting the electrode portions and the optrode portion, and laminated on the substrate portion using hot pressing so as to expose a part of the optrode portion.
11. The electro-optrode neural interface of claim 10, wherein the electrode portions are formed by patterning a metal material on the substrate portion.
12. The electro-optrode neural interface of claim 10, wherein the optrode portion is formed by patterning a photopolymer on the substrate portion.
13. A method of manufacturing an LCP-based electro-optrode neural interface, comprising:
forming electrode portions on an upper side of a substrate portion made of LCP;
forming an optrode portion on the upper side of the substrate portion so as not to overlap with the electrode portions;
laminating a cover portion made of LCP on the substrate portion so as to expose a part of the optrode portion; and
cutting a region of the substrate portion other than the electrode portions and the optrode portion of the substrate portion laminated with the cover portion, thus manufacturing the electro-optrode neural interface.
14. The method of claim 13, further comprising:
forming an alignment hole in the electro-optrode neural interface; and
connecting a feed-through to the electro-optrode neural interface using the alignment hole.
US13/880,421 2010-10-21 2011-10-19 Liquid crystal polymer-based electro-optrode neural interface, and method for producing same Abandoned US20130237906A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR20100103026 2010-10-21
KR1020100103026 2010-10-21
KR1020110090040A KR101304338B1 (en) 2010-10-21 2011-09-06 LCP-based electro-optrode neural interface and Method for fabricating the same
KR1020110090040 2011-09-06
PCT/KR2011/007778 WO2012053815A2 (en) 2010-10-21 2011-10-19 Liquid crystal polymer-based electro-optrode neural interface, and method for producing same

Publications (1)

Publication Number Publication Date
US20130237906A1 true US20130237906A1 (en) 2013-09-12

Family

ID=46873771

Family Applications (1)

Application Number Title Priority Date Filing Date
US13/880,421 Abandoned US20130237906A1 (en) 2010-10-21 2011-10-19 Liquid crystal polymer-based electro-optrode neural interface, and method for producing same

Country Status (8)

Country Link
US (1) US20130237906A1 (en)
EP (1) EP2630986B1 (en)
JP (1) JP2013543743A (en)
KR (1) KR101304338B1 (en)
CN (1) CN103167892B (en)
AU (1) AU2011318749A1 (en)
SG (1) SG189526A1 (en)
WO (1) WO2012053815A2 (en)

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150018901A1 (en) * 2013-07-11 2015-01-15 Board Of Trustees Of Michigan State University Neural prosthetic device and method of making same
WO2015094076A1 (en) 2013-12-20 2015-06-25 Neuronano Ab Medical device comprising an electrode and a light source
US20160175606A1 (en) * 2014-12-17 2016-06-23 Gwangju Institute Of Science And Technology Optical stimulator using electrochromism
WO2017015395A1 (en) * 2015-07-21 2017-01-26 The Board Of Trustees Of The Leland Stanford Junior University Carbon fiber optrodes for magnetic resonance imaging compatible optogenetics
US20170232250A1 (en) * 2014-08-08 2017-08-17 Seoul National University R&Db Foundation Liquid crystal polymer-based electrode array and package for neural implant, and manufacturing method therefor
US10195429B1 (en) 2017-08-02 2019-02-05 Lungpacer Medical Inc. Systems and methods for intravascular catheter positioning and/or nerve stimulation
US10293164B2 (en) 2017-05-26 2019-05-21 Lungpacer Medical Inc. Apparatus and methods for assisted breathing by transvascular nerve stimulation
WO2019109002A1 (en) * 2017-11-30 2019-06-06 Case Western Reserve University System for long-term modulation of peripheral nerve activity with light
US10391314B2 (en) 2014-01-21 2019-08-27 Lungpacer Medical Inc. Systems and related methods for optimization of multi-electrode nerve pacing
US10406367B2 (en) 2012-06-21 2019-09-10 Lungpacer Medical Inc. Transvascular diaphragm pacing system and methods of use
US10512772B2 (en) 2012-03-05 2019-12-24 Lungpacer Medical Inc. Transvascular nerve stimulation apparatus and methods
US10561843B2 (en) 2007-01-29 2020-02-18 Lungpacer Medical, Inc. Transvascular nerve stimulation apparatus and methods
US10940308B2 (en) 2017-08-04 2021-03-09 Lungpacer Medical Inc. Systems and methods for trans-esophageal sympathetic ganglion recruitment
US10987511B2 (en) 2018-11-08 2021-04-27 Lungpacer Medical Inc. Stimulation systems and related user interfaces
US20220118258A1 (en) * 2017-05-26 2022-04-21 Newton Howard Brain monitoring and stimulation devices and methods
US11357979B2 (en) 2019-05-16 2022-06-14 Lungpacer Medical Inc. Systems and methods for sensing and stimulation
US11504038B2 (en) 2016-02-12 2022-11-22 Newton Howard Early detection of neurodegenerative disease
CN116164859A (en) * 2023-02-17 2023-05-26 之江实验室 A high-sensitivity temperature sensor based on double-helix micro-nano fiber structure
US11707619B2 (en) 2013-11-22 2023-07-25 Lungpacer Medical Inc. Apparatus and methods for assisted breathing by transvascular nerve stimulation
US11771900B2 (en) 2019-06-12 2023-10-03 Lungpacer Medical Inc. Circuitry for medical stimulation systems
US20230408404A1 (en) * 2020-04-06 2023-12-21 Joyson Safety Systems Acquisition Llc Systems and methods of ambient gas sensing in a vehicle
US11883658B2 (en) 2017-06-30 2024-01-30 Lungpacer Medical Inc. Devices and methods for prevention, moderation, and/or treatment of cognitive injury
US11957897B2 (en) 2016-04-22 2024-04-16 Newton Howard Biological co-processor (BCP)
US11998739B2 (en) 2017-07-12 2024-06-04 Cochlear Limited Monolithic component for an implantable medical device
US12029903B2 (en) 2017-12-11 2024-07-09 Lungpacer Medical Inc. Systems and methods for strengthening a respiratory muscle
US12379130B2 (en) 2021-04-06 2025-08-05 Joyson Safety Systems Acquisition Llc Gas monitoring device and system
US12428543B2 (en) 2021-05-18 2025-09-30 Ticona Llc Connected medical device containing a liquid crystalline polymer composition having a low dielectric constant

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE537219C2 (en) * 2013-03-15 2015-03-03 Karin Wårdell Combination probe for location, registration and operative stimulation of a target tissue
US9986914B2 (en) * 2013-05-24 2018-06-05 University Of Houston System Method of fabricating a probe
CN103462600B (en) * 2013-09-04 2015-04-15 中国科学院深圳先进技术研究院 Photoelectrode component and in-vivo photoelectrode imaging system
KR101537932B1 (en) * 2013-10-01 2015-07-20 서울대학교산학협력단 Polymer-based hybrid neural electrode array with fluidic channel and manufacturing method thereof
KR101518245B1 (en) * 2014-06-17 2015-05-11 한국과학기술연구원 Neural Probe Array having a channel for injecting medical substances
DE102014014942A1 (en) * 2014-10-07 2016-04-07 Neuroloop GmbH Implantable arrangement
JPWO2016185525A1 (en) * 2015-05-15 2018-03-01 合同会社プロモベオ Brain electrode
FR3036623B1 (en) * 2015-05-28 2017-05-19 Commissariat Energie Atomique DEVICE FOR DEEP ELECTRICAL AND OPTICAL STIMULATION OF THE BRAIN
KR101731231B1 (en) * 2015-07-31 2017-04-28 재단법인 오송첨단의료산업진흥재단 Implantable hybrid lead and a method of manufacturing the same
WO2017204610A1 (en) * 2016-05-27 2017-11-30 주식회사 토닥 Bio-implantable device and method for manufacturing same
CN106291813A (en) * 2016-09-07 2017-01-04 中国科学院半导体研究所 Many measuring points transparent optical electrode based on optical fiber
JP7329442B2 (en) * 2017-01-19 2023-08-18 セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド Sheath visualization
CN109199377A (en) * 2017-07-03 2019-01-15 诺尔医疗(深圳)有限公司 Intracranical deep electrode and medical instrument
WO2019020985A1 (en) 2017-07-28 2019-01-31 Galvani Bioelectronics Limited Electrode devices for neurostimulation
CN107638175B (en) * 2017-08-24 2020-12-01 国家纳米科学中心 A flexible electrode array-fiber composite nerve electrode and preparation method thereof
CN109431464B (en) * 2018-10-25 2021-05-18 惠良图 Multifunctional anesthesia depth monitoring device for anesthesia department
KR102344758B1 (en) * 2019-12-10 2021-12-30 사회복지법인 삼성생명공익재단 Implantable medical device capable of releasing anti-inflammatory agents
WO2021141163A1 (en) * 2020-01-09 2021-07-15 서울시립대학교 산학협력단 Deep brain stimulation transparent electrode array and neural signal detection method using same
CN111437514A (en) * 2020-03-31 2020-07-24 北京航空航天大学 Optical fiber probe for simultaneously realizing deep brain light stimulation and electroencephalogram detection and preparation method thereof
CN112121306B (en) * 2020-06-05 2024-04-19 未来穿戴技术有限公司 Electrode plate manufacturing method, electrode plate and neck massager
CN112099160B (en) * 2020-08-14 2021-06-22 中国科学院上海微系统与信息技术研究所 Back-end connection structure of an implantable neural photoelectrode and preparation method thereof
CN115227419A (en) * 2022-08-24 2022-10-25 苏州密尔光子科技有限公司 A kind of laser swing cleaning equipment and method
CN116035588B (en) * 2023-01-13 2023-11-07 光子集成(温州)创新研究院 Neural interface and heart monitor based on neural interface

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090156918A1 (en) * 2007-12-12 2009-06-18 Davis Timothy J Implantable optical sensor and method for use
US7666284B2 (en) * 2000-05-12 2010-02-23 Abbott Diabetes Care Inc. Electrodes with multilayer membranes and methods of using and making the electrodes

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023495A1 (en) * 1992-05-20 1993-11-25 Neste Oy Electrically conducting liquid-crystal polymers and process for preparation thereof
GB2277323A (en) * 1993-04-06 1994-10-26 Secr Defence Liquid crystal polymers
GB2304723B (en) * 1995-09-05 2000-04-05 Peter Jonathan Samuel Foot Liquid-crystalline conducting polymers
JP4118062B2 (en) * 2002-02-07 2008-07-16 株式会社ニデック Intraocular implant device
US7480433B2 (en) * 2002-02-19 2009-01-20 Tufts University Electro-optical stimulation/measurement
US6644552B1 (en) 2002-07-09 2003-11-11 John Herslow Composite card
US7316789B2 (en) * 2004-11-02 2008-01-08 International Business Machines Corporation Conducting liquid crystal polymer nature comprising carbon nanotubes, use thereof and method of fabrication
JP2008520280A (en) * 2004-11-15 2008-06-19 デチャームス,クリストファー Application of nerve tissue stimulation using light
US9238150B2 (en) * 2005-07-22 2016-01-19 The Board Of Trustees Of The Leland Stanford Junior University Optical tissue interface method and apparatus for stimulating cells
US20090093403A1 (en) * 2007-03-01 2009-04-09 Feng Zhang Systems, methods and compositions for optical stimulation of target cells
US20080027347A1 (en) * 2006-06-23 2008-01-31 Neuro Vista Corporation, A Delaware Corporation Minimally Invasive Monitoring Methods
US8160696B2 (en) * 2008-10-03 2012-04-17 Lockheed Martin Corporation Nerve stimulator and method using simultaneous electrical and optical signals
JP5216230B2 (en) * 2007-03-29 2013-06-19 Jx日鉱日石エネルギー株式会社 Conductive resin composition
US10434327B2 (en) * 2007-10-31 2019-10-08 The Board Of Trustees Of The Leland Stanford Junior University Implantable optical stimulators
KR101028949B1 (en) 2008-07-23 2011-04-12 재단법인서울대학교산학협력재단 Neuronal user interface devices, methods and devices for measuring brain activity
KR20100056872A (en) 2008-11-20 2010-05-28 김현피 Valve apparatus
KR101045866B1 (en) 2008-11-20 2011-07-01 서울대학교산학협력단 Neural signal measuring apparatus and method using optical fiber
KR101051025B1 (en) * 2008-12-23 2011-07-26 한국과학기술연구원 Brain stimulation and measurement apparatus and method of manufacturing the same
KR101088806B1 (en) 2009-01-07 2011-12-01 주식회사 뉴로바이오시스 Microelectrode array package using liquid crystal polymer and manufacturing method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666284B2 (en) * 2000-05-12 2010-02-23 Abbott Diabetes Care Inc. Electrodes with multilayer membranes and methods of using and making the electrodes
US20090156918A1 (en) * 2007-12-12 2009-06-18 Davis Timothy J Implantable optical sensor and method for use

Cited By (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10864374B2 (en) 2007-01-29 2020-12-15 Lungpacer Medical Inc. Transvascular nerve stimulation apparatus and methods
US10792499B2 (en) 2007-01-29 2020-10-06 Lungpacer Medical Inc. Transvascular nerve stimulation apparatus and methods
US12268877B2 (en) 2007-01-29 2025-04-08 Lungpacer Medical Inc. Transvascular nerve stimulation apparatus and methods
US10765867B2 (en) 2007-01-29 2020-09-08 Lungpacer Medical Inc. Transvascular nerve stimulation apparatus and methods
US10561843B2 (en) 2007-01-29 2020-02-18 Lungpacer Medical, Inc. Transvascular nerve stimulation apparatus and methods
US11027130B2 (en) 2007-01-29 2021-06-08 Lungpacer Medical Inc. Transvascular nerve stimulation apparatus and methods
US10512772B2 (en) 2012-03-05 2019-12-24 Lungpacer Medical Inc. Transvascular nerve stimulation apparatus and methods
US11369787B2 (en) 2012-03-05 2022-06-28 Lungpacer Medical Inc. Transvascular nerve stimulation apparatus and methods
US11357985B2 (en) 2012-06-21 2022-06-14 Lungpacer Medical Inc. Transvascular diaphragm pacing systems and methods of use
US10406367B2 (en) 2012-06-21 2019-09-10 Lungpacer Medical Inc. Transvascular diaphragm pacing system and methods of use
US10561844B2 (en) 2012-06-21 2020-02-18 Lungpacer Medical Inc. Diaphragm pacing systems and methods of use
US10589097B2 (en) 2012-06-21 2020-03-17 Lungpacer Medical Inc. Transvascular diaphragm pacing systems and methods of use
US20150018901A1 (en) * 2013-07-11 2015-01-15 Board Of Trustees Of Michigan State University Neural prosthetic device and method of making same
US10004917B2 (en) * 2013-07-11 2018-06-26 Board Of Trustees Of Michigan State University Neural prosthetic device and method of making same
US11707619B2 (en) 2013-11-22 2023-07-25 Lungpacer Medical Inc. Apparatus and methods for assisted breathing by transvascular nerve stimulation
US12239838B2 (en) 2013-11-22 2025-03-04 Lungpacer Medical Inc. Apparatus and methods for assisted breathing by transvascular nerve stimulation
US11583233B2 (en) 2013-12-20 2023-02-21 Neuronano Ab Medical device comprising an electrode and a light source
WO2015094076A1 (en) 2013-12-20 2015-06-25 Neuronano Ab Medical device comprising an electrode and a light source
US11311730B2 (en) 2014-01-21 2022-04-26 Lungpacer Medical Inc. Systems and related methods for optimization of multi-electrode nerve pacing
US10391314B2 (en) 2014-01-21 2019-08-27 Lungpacer Medical Inc. Systems and related methods for optimization of multi-electrode nerve pacing
US12172020B2 (en) 2014-01-21 2024-12-24 Lungpacer Medical Inc. Systems and related methods for optimization of multi-electrode nerve pacing
US10500393B2 (en) * 2014-08-08 2019-12-10 Seoul National University R&Db Foundation Liquid crystal polymer-based electrode array and package for neural implant, and manufacturing method therefor
US20170232250A1 (en) * 2014-08-08 2017-08-17 Seoul National University R&Db Foundation Liquid crystal polymer-based electrode array and package for neural implant, and manufacturing method therefor
US20160175606A1 (en) * 2014-12-17 2016-06-23 Gwangju Institute Of Science And Technology Optical stimulator using electrochromism
US11684284B2 (en) 2015-07-21 2023-06-27 The Board Of Trustees Of The Leland Stanford Junior University Carbon fiber optrodes for magnetic resonance imaging compatible optogenetics
WO2017015395A1 (en) * 2015-07-21 2017-01-26 The Board Of Trustees Of The Leland Stanford Junior University Carbon fiber optrodes for magnetic resonance imaging compatible optogenetics
US11504038B2 (en) 2016-02-12 2022-11-22 Newton Howard Early detection of neurodegenerative disease
US11957897B2 (en) 2016-04-22 2024-04-16 Newton Howard Biological co-processor (BCP)
US20220118258A1 (en) * 2017-05-26 2022-04-21 Newton Howard Brain monitoring and stimulation devices and methods
US10293164B2 (en) 2017-05-26 2019-05-21 Lungpacer Medical Inc. Apparatus and methods for assisted breathing by transvascular nerve stimulation
US12029901B2 (en) 2017-06-30 2024-07-09 Lungpacer Medical Inc. Devices and methods for prevention, moderation, and/or treatment of cognitive injury
US11883658B2 (en) 2017-06-30 2024-01-30 Lungpacer Medical Inc. Devices and methods for prevention, moderation, and/or treatment of cognitive injury
US11998739B2 (en) 2017-07-12 2024-06-04 Cochlear Limited Monolithic component for an implantable medical device
US10195429B1 (en) 2017-08-02 2019-02-05 Lungpacer Medical Inc. Systems and methods for intravascular catheter positioning and/or nerve stimulation
US10926087B2 (en) 2017-08-02 2021-02-23 Lungpacer Medical Inc. Systems and methods for intravascular catheter positioning and/or nerve stimulation
US11090489B2 (en) 2017-08-02 2021-08-17 Lungpacer Medical, Inc. Systems and methods for intravascular catheter positioning and/or nerve stimulation
US12029902B2 (en) 2017-08-02 2024-07-09 Lungpacer Medical Inc. Intravascular catheter methods
US11944810B2 (en) 2017-08-04 2024-04-02 Lungpacer Medical Inc. Systems and methods for trans-esophageal sympathetic ganglion recruitment
US10940308B2 (en) 2017-08-04 2021-03-09 Lungpacer Medical Inc. Systems and methods for trans-esophageal sympathetic ganglion recruitment
WO2019109002A1 (en) * 2017-11-30 2019-06-06 Case Western Reserve University System for long-term modulation of peripheral nerve activity with light
EP4272811A3 (en) * 2017-11-30 2024-02-07 Case Western Reserve University System for long-term modulation of peripheral nerve activity with light
US12029903B2 (en) 2017-12-11 2024-07-09 Lungpacer Medical Inc. Systems and methods for strengthening a respiratory muscle
US10987511B2 (en) 2018-11-08 2021-04-27 Lungpacer Medical Inc. Stimulation systems and related user interfaces
US11890462B2 (en) 2018-11-08 2024-02-06 Lungpacer Medical Inc. Stimulation systems and related user interfaces
US11717673B2 (en) 2018-11-08 2023-08-08 Lungpacer Medical Inc. Stimulation systems and related user interfaces
US11357979B2 (en) 2019-05-16 2022-06-14 Lungpacer Medical Inc. Systems and methods for sensing and stimulation
US12403312B2 (en) 2019-06-12 2025-09-02 Lungpacer Medical Inc. Circuitry for medical stimulation systems
US11771900B2 (en) 2019-06-12 2023-10-03 Lungpacer Medical Inc. Circuitry for medical stimulation systems
US12313536B2 (en) * 2020-04-06 2025-05-27 Joyson Safety Systems Acquisition Llc Systems and methods of ambient gas sensing in a vehicle
US20230408404A1 (en) * 2020-04-06 2023-12-21 Joyson Safety Systems Acquisition Llc Systems and methods of ambient gas sensing in a vehicle
US12379130B2 (en) 2021-04-06 2025-08-05 Joyson Safety Systems Acquisition Llc Gas monitoring device and system
US12428543B2 (en) 2021-05-18 2025-09-30 Ticona Llc Connected medical device containing a liquid crystalline polymer composition having a low dielectric constant
CN116164859A (en) * 2023-02-17 2023-05-26 之江实验室 A high-sensitivity temperature sensor based on double-helix micro-nano fiber structure

Also Published As

Publication number Publication date
JP2013543743A (en) 2013-12-09
SG189526A1 (en) 2013-05-31
AU2011318749A1 (en) 2013-06-06
KR101304338B1 (en) 2013-09-11
WO2012053815A3 (en) 2012-07-26
KR20120088501A (en) 2012-08-08
CN103167892B (en) 2015-04-01
WO2012053815A2 (en) 2012-04-26
EP2630986B1 (en) 2014-12-10
CN103167892A (en) 2013-06-19
EP2630986A4 (en) 2014-04-16
EP2630986A2 (en) 2013-08-28

Similar Documents

Publication Publication Date Title
EP2630986B1 (en) Liquid crystal polymer-based electro-optrode neural interface, and method for producing same
US20230045240A1 (en) Deep brain stimulation transparent electrode array and neural signal detection method using same
Choi et al. Stretchable, dynamic covalent polymers for soft, long-lived bioresorbable electronic stimulators designed to facilitate neuromuscular regeneration
Lee et al. Soft high-resolution neural interfacing probes: Materials and design approaches
KR102128092B1 (en) Deep brain stimulation transparent electrodes array and neural signal detection method using the same
Lu et al. Polymer fiber probes enable optical control of spinal cord and muscle function in vivo
Sung et al. Flexible wireless powered drug delivery system for targeted administration on cerebral cortex
Lee et al. A flexible depth probe using liquid crystal polymer
ES2719955T3 (en) Systems for evaluation and modification of traffic and neurological receptors
Yan et al. Ultraflexible and stretchable intrafascicular peripheral nerve recording device with axon‐dimension, cuff‐less microneedle electrode array
Lee et al. Nanoenabled direct contact interfacing of syringe-injectable mesh electronics
Pothof et al. Chronic neural probe for simultaneous recording of single-unit, multi-unit, and local field potential activity from multiple brain sites
US20150080695A1 (en) Conformable Actively Multiplexed High-Density Surface Electrode Array for Brain Interfacing
KR102140137B1 (en) Deep brain stimulation transparent electrodes array and neural signal detection method using the same
KR20130087202A (en) Neuro device having nano wire and supporting layer
Poppendieck et al. Development, manufacturing and application of double-sided flexible implantable microelectrodes
Khatib et al. High-density soft bioelectronic fibres for multimodal sensing and stimulation
US20240057943A1 (en) Multilayer and bouquet fiber-based neural probes and methods of making and uses thereof
Zhou et al. Intraoperative Nerve Mapping and Visualization System: Optimal Neurological Function Preservation in Schwannoma Surgery
Deng et al. Minimally Invasive Micro‐Hole Intervention for Wireless Intracranial Pressure Measurement
Liu et al. Developing clinical grade flexible implantable electronics
Byun et al. Development of integrated flexible penetrating microelectrode array with interconnection cable for use in various nervous systems
Kim et al. Flexible thin film electrode arrays for minimally-invasive neurological monitoring
배재영 Fully Biodegradable and Axis Transformable Soft Electronics for Minimally Invasive Brain Cortex Interfaces
CN120616552A (en) Minimally invasive electrocorticography brain-computer interface

Legal Events

Date Code Title Description
AS Assignment

Owner name: M.I.TECH CO., LTD., KOREA, REPUBLIC OF

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PARK, SE-IK;CHANG, JIN-WOO;KIM, SUNG JUNE;AND OTHERS;SIGNING DATES FROM 20130410 TO 20130411;REEL/FRAME:030250/0939

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION